No recent analyst price targets found for PPLPHARMA.NS.
Latest News for PPLPHARMA.NS
Le rapport annuel de Piramal Pharma pour l'exercice 2026 souligne l'envergure mondiale de la société, sa croissance axée sur l'innovation et ses avancées majeures en matière de développement durable
/PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), l'un des leaders mondiaux du secteur pharmaceutique, de la santé et du bien-être,
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits PR Newswire MUMBAI,
Piramal Pharma Solutions enthüllt hochmoderne Payload-Linker-Suite in seinem Werk in Riverview, Michigan
Die Anlage in Riverview bietet umfassende Dienstleistungen für pharmazeutische Wirkstoffe (Active Pharmaceuticals Ingredients, APIs) und hochwirksame
Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility PR Newswire
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PPLPHARMA.NS.
Senate Trading
No Senate trades found for PPLPHARMA.NS.
U.S. House Trading
No House trades found for PPLPHARMA.NS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.